Immunoaffinity resin for purification of urinary leukotriene E4. (Q47882940)

6 February 2018

title

Immunoaffinity resin for purification of urinary leukotriene E4. (English)

1 reference

6 February 2018

author name string

J Y Westcott

1

1 reference

6 February 2018

K M Maxey

2

1 reference

6 February 2018

J MacDonald

3

1 reference

6 February 2018

S E Wenzel

4

1 reference

6 February 2018

publication date

1 April 1998

1 reference

6 February 2018

Prostaglandins and Other Lipid Mediators

published in

1 reference

6 February 2018

volume

55

1 reference

6 February 2018

issue

5-6

1 reference

6 February 2018

page(s)

301-321

1 reference

6 February 2018

Sulphidopeptide leukotrienes in asthma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

The role of leukotrienes in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

In vivo metabolism of leukotriene C4 in man: urinary excretion of leukotriene E4

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

Measurement of peptidoleukotrienes in biological fluids

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

Urinary Leukotriene E4Concentrations Increase after Aspirin Challenge in Aspirin-sensitive Asthmatic Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

Enhanced synthesis of cysteinyl leukotrienes in juvenile rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

Enhanced excretion of urinary leukotriene E4 in coronary artery disease and after coronary artery bypass surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

Diurnal variation of urinary leukotriene E4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

Validation and application of a new simple strategy for measurements of urinary leukotriene E4 in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

Analytical methods for the measurement of leukotrienes and other eicosanoids in biological samples from asthmatic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

Immunofiltration purification for urinary leukotriene E4 quantitation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

A monoclonal antibody against the sulfidopeptide leukotrienes LTC4, LTD4 and LTE4

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

BIO-Fully Automated Sample Treatment high-performance liquid chromatography and radioimmunoassay for leukotriene E4 in human urine from asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

N-acetyl[3H]leukotriene D4: a stable internal standard for automated BIO-FAST HPLC extraction and separation of LTE4 from human urine

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

Urinary leukotriene E4 in patients with asthma. Effect of airways reactivity and sodium cromoglycate

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

Enhanced synthesis of cysteinyl leukotrienes in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

Allergen-stimulated release of thromboxane A2 and leukotriene E4 in humans. Effect of indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

Urinary leukotriene E after exercise challenge in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

Urinary Excretion of Leukotriene E4and 11-dehydro-Thromboxane B2in Response to Bronchial Provocations with Allergen, Aspirin, Leukotriene D4, and Histamine in Asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

The effect of aspirin desensitization on urinary leukotriene E4 concentrations in aspirin-sensitive asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

The Pivotal Role of 5-Lipoxygenase Products in the Reaction of Aspirin-sensitive Asthmatics to Aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

Elevated urinary leukotriene E4 excretion in patients with ARDS and severe burns

1 reference

https://api.crossref.org/works/10.1016%2FS0090-6980%2898%2900027-6

7 January 2021

10.1016/S0090-6980(98)00027-6

Identifiers

DOI

1 reference

6 February 2018

release_is6seltilbemzcooxxqakbhpam

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/is6seltilbemzcooxxqakbhpam

24 November 2022

mapped directly with Wikidata item

1 reference

6 February 2018